During the past decade, Regenerative Solutions conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regenerative Solutions" #1 collaborator was "Medelis Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Regenerative Solutions" are "Alveolar Bone Loss" (1 trials), "Periodontal Diseases" (1 trials), "Periodontitis" (1 trials) and "Soft Tissue Defect" (1 trials). Many other conditions were trialed in "Regenerative Solutions" in a lesser frequency.

Most popular intervention types in "Regenerative Solutions" are "Device" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "GFeBGS 0.1%" (1 trials), "GFeBGS 0.3%" (1 trials), "GFeBGS 0.4%" (1 trials), "PerioSept(r)" (1 trials) and "Soft tissue flap + Connective Tissue Graft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regenerative Solutions" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Regenerative Solutions". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Regenerative Solutions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regenerative Solutions, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".